News
The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.
Hospital groups are celebrating a federal judge’s initial ruling against pharmaceutical makers who contended a government ...
Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...
U.S. health officials on Friday endorsed the first blood test that can help diagnose Alzheimer’s and identify patients who ...
The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.
By Patrick Wingrove and Maggie Fick (Reuters) -As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard ...
Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...
Eli Lilly's potential Houston expansion could bring thousands of jobs and billions of dollars in investment to the area. Here ...
In a press release announcing the move, Novo Nordisk cited market challenges and its declining share price in a press release ...
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...
10h
Pharmaceutical Technology on MSNEli Lilly strikes $1.3bn gene therapy deal with RznomicsThe deal gives Lilly access to the company’s RNA-editing platform to develop therapies for sensorineural hearing loss.
Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results